Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Looking Into Avid Bioservices's Return On Capital Employed

According to Benzinga Pro, during Q4, Avid Bioservices (NASDAQ:CDMO) earned $115.60 million, a 5042.26% increase from the preceding quarter. Avid Bioservices's sales decreased to $31.23 million, a 0.9% change since Q3.

Benzinga

Patterson Companies's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, Patterson Companies (NASDAQ:PDCO) earned $63.40 million, a 12.06% increase from the preceding quarter. Patterson Companies also posted a total of $1.64 billion in sales, a 2.63% increase since Q3.

Benzinga

Bed Bath & Beyond's Return On Capital Employed Insights

Benzinga Pro data, Bed Bath & Beyond (NASDAQ:BBBY) reported Q1 sales of $1.46 billion. Earnings fell to a loss of $357.67 million, resulting in a 124.8% decrease from last quarter.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity

Codiak BioSciences Inc (NASDAQ:CDAK) announced platform-validating clinical data from Phase 1 trials of exoSTING and exoIL-12, and it plans to advance both candidates into Phase 2 trials. In an open-label Phase 1 trial, exoIL-12 demonstrated a differentiating favorable safety and tolerability profile, with no detectable systemic exposure of IL-12 and no treatment-related adverse…

Benzinga

Nemaura Medical: Q4 Earnings Insights

Nemaura Medical (NASDAQ:NMRD) reported its Q4 earnings results on Thursday, June 30, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Why U.S. Stocks Are Trading Sharply Lower, Jobless Claims Report And More

U.S. stocks traded lower this morning, with the Dow Jones dropping around 450 points on Thursday.

Benzinga

What 7 Analyst Ratings Have To Say About Comcast

Analysts have provided the following ratings for Comcast (NASDAQ:CMCSA) within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings for T. Rowe Price Gr

T. Rowe Price Gr (NASDAQ:TROW) has observed the following analyst ratings within the last quarter:

Benzinga

Nvidia, Apple, Microsoft And Others Set To Lose As Gartner Predicts Demand Softness For Smartphones, PCs In 2022

China's economic slowdown and inflation-led drop in consumer spending will likely weigh on the global shipments of computers and smartphones in 2022, as per a Reuters story citing research firm Gartner. Earlier this month, Advanced Micro Devices, Inc (NASDAQ:AMD) warned against a slowdown in the PC market after two solid years. Analysts expected the chipmaker to gain…

Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, NeuroSense reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed that levels of disease-related biomarkers in people with ALS were unchanged, in contrast…

Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

3 Stocks Under $2 Insiders Are Aggressively Buying

U.S. stock futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

Benzinga

Walgreens Posts Fall In Q3 Profit On Opioid Settlement, Lower Pharmacy Sales

Walgreens Boots Alliance Inc's (NASDAQ:WBA) Q3 FY22 sales decreased 4.2% Y/Y to $32.6 billion, down 2.8% on a constant currency basis, beating the consensus of $32.06 billion. Adjusted EPS reached $0.96, beating the consensus of $0.92, down 28.9% on a constant currency basis against 93.6% growth a year ago that reflected peak…

Benzinga

It's been a vicious 6 months for stocks. Here's what the grim markets are signaling

All that whipsawing on Wall Street in the first half of the year reflects real nervousness. Investors are worried the Fed may tip the economy into a recession.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

3 Stocks Insiders Are Buying: Children's Place And More

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.

Benzinga

Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30

Reuters Hyundai, Affiliates Plan To Set Up New Company In US:

Benzinga

Recap: Simply Good Foods Q3 Earnings

Simply Good Foods (NASDAQ:SMPL) reported its Q3 earnings results on Thursday, June 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

This Stock May Rally Even As Other Chip Stocks Dip

Micron Technology, Inc. (NASDAQ: MU) is scheduled to report its quarterly earnings after the closing bell on June 30.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Avadel Cuts Workforce, Optimizes Cost Structure To Support This

Avadel Pharmaceuticals plc (NASDAQ: AVDL) announced its steps to explore every available pathway to accelerate the FDA approval of its lead drug candidate, FT218, before June 2023.

Benzinga

Xerox Names COO Steve Bandrowczak As Interim CEO After John Visentin Dies Due To Ongoing Illness

Xerox Holdings Corp (NASDAQ:XRX) CEO John Visentin abruptly passed away on June 29 due to complications from an ongoing illness. Since joining Xerox in May 2018, John has been known for his "One Boat, One Team" call to action and mentality. COO Steve Bandrowczak will serve as interim CEO. Xerox registered a first-quarter FY22 sales…

Benzinga

Canopy Growth Enters Into Exchange Agreements With Holders Of Approximately $198M Of Convertible Notes

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) has entered into privately negotiated exchange agreements with a limited number of holders, including Constellation Brands, Inc. (NYSE: STZ) through its wholly-owned s

Benzinga

Coinbase To Merge USD, USDC Order Books For 'Deeper Liquidity'

Crypto exchange Coinbase Global Inc (NASDAQ: COIN) plans to merge its U.S. dollar order book with its USD Coin (CRYPTO: USDC) order book.

Benzinga

Nexstar Nears Deal To Snap Majority Control In CW Network: WSJ

Nexstar Media Group, Inc (NASDAQ:NXST) is on the verge of acquiring majority control of the CW Network from Warner Bros. Discovery, Inc (NASDAQ:WBD) and Paramount Global (NASDAQ:PARA), the Wall Street Journal reports. The leading owner of local television stations would acquire 75% of the CW, a broadcast network aimed primarily at teens and young adults, with…

Benzinga

AstraZeneca Says Imfinzi/Chemo Combo Shows Promising Action In Late-Stage Lung Cancer Study

AstraZeneca Plc (NASDAQ:AZN) announced high-level results from a planned interim analysis of the AEGEAN Phase 3 trial of Imfinzi (durvalumab) combined with neoadjuvant chemotherapy in patients with resectable non-small cell lung cancer (NSCLC). The data showed that Imfinzi plus neoadjuvant chemo before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete…

Benzinga

Why Sanofi Shares Are Falling Today

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug. The participants who…

1 … 338 339 340 341

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.